CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Par Pharmaceutical, Inc. et al. vs. Novartis AG

Explore the PTAB proceeding IPR2016-00074 filed by Par Pharmaceutical, Inc. et al. on 2015-10-26. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-00074

Filing Date

2015-10-26

Accorded Filing Date

2015-10-26

Institution Decision Date

2016-04-01

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

2016-04-01

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12497728
Respondent Patent Number 7741338
Legal Expiration Date
2029-07-06 Active (2.6 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Francois Navarro et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Settlement 2016-04-01
Order - Termination of Proceedings
37 CFR 42.72, 37 CFR 42.74, 35 USC 317

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVARTIS PHARMACEUTICAL CORPORATION - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 1095
Address 250 Massachusetts Avenue, Cambridge, MA, 02139, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 2 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 1 proceeding
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): GB ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 1 U.S. Courts: 2
USPTO PTAB Trial 2015-10-26
IPR2016-00075

Par Pharmaceutical, Inc. et al. v. Novartis AG

U.S. Continuation Sibling (7297703)
Status: Institution Denied
U.S. District Court 2017-04-07
1:17-cv-00389

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.

U.S. Family Sibling (["US5665772", "US8778962", "US8617598", "US7297703"])
Status: DED
U.S. District Court 2016-06-13
1:16-cv-00431

Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

34
17

Notice of Refund Paper

2016-04-07 FILING PARTY: BOARD
16

Petitioner's Request for Refund of Post-Institution Fee Paper

2016-04-04 FILING PARTY: PETITIONER
15

Order - Termination of Proceedings Paper

2016-04-01 FILING PARTY: BOARD
12

Joint Request to File Agreement As Business Confidential Information Paper

2016-03-31 FILING PARTY: PETITIONER
14

Petitioner's Updated Exhibit List Paper

2016-03-31 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc